Home » Media

Media

BIO Testifies on Importance of Prompt Enactment of PDUFA V Recommendations
In the testimony, Richard Pops, Alkermes plc Chairman and CEO,  stressed the need for a quick reauthorization of the Prescription Drug User...
BIO Applauds Sen. Stabenow’s Bill to Extend Advanced Energy Project Credit to Renewable Chemicals and Biobased Products
Biobased products and renewable chemicals can contribute to energy security and create new jobs and so should be eligible for advanced energy project credits.

Press Releases

BIO Asks EPA to Reject Retroactive Changes to Renewable Fuel Standard
Feb 17 2012
A petition to retroactively change the Renewable Fuel Standard (RFS) for 2011 would undermine the industry’s progress in commercializing advanced...
BIO Plenary Speakers for the 2012 World Congress on Industrial Biotechnology and Bioprocessing to Address Advanced Biofuels, Renewable Chemicals and Creation of a Biobased Economy
Feb 16 2012
WASHINGTON, D.C. (Feb. 16, 2012) – Company executives, scientists and government officials will bring a global perspective as featured presenters at...
TREAT Act Offers Renewed Hope for Patients
Feb 15 2012
Washington, DC (February 15, 2012) – Today, the Biotechnology Industry Organization (BIO) praised Sen. Kay Hagan (D-NC) for introducing the...
BIO Industry Analysis Investor Survey: FDA Approvals Expected to Increase and Majority of Investors Believe Now is a Good Time to Invest in Biotech
Feb 15 2012
WASHINGTON, DC (February 15, 2012) – The 14th annual BIO CEO & Investor Conference wrapped up in New York City yesterday amidst renewed optimism...
Administration‘s 2013 Budget Could Discourage Development of Cures and Breakthrough Medicines, Limit Patient Choice And Forestall Job Growth
Feb 14 2012
  (February 14, 2011) –Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement in response to...
BIO’s 9th Annual World Congress on Industrial Biotechnology and Bioprocessing in Orlando to Feature Presentations on Advanced Biofuels and Renewable Chemicals
Feb 9 2012
  WASHINGTON, D.C. (Feb. 9, 2012) – Biofuel and renewable chemical company executives, scientists and government officials from around the globe...
Release of FDA Guidance for Biosimilars Pathway Marks Important Step Forward, Says BIO
Feb 9 2012
Patient Safety Must Remain Top Priority Washington, D.C. (February 9, 2012) — Biotechnology Industry Organization (BIO) President and CEO Jim...
More Farmers Favor Biotech Crops
Feb 7 2012
Adoption of Agricultural Biotechnology Increased Eight Percent Over Past Year WASHINGTON, D.C. (February 07, 2012) – Because of their tremendous...
BIO Testifies on Importance of Prompt Enactment of PDUFA V Recommendations
Feb 1 2012
Washington, D.C. (February 1, 2012) – Richard Pops, Chairman and CEO of Alkermes plc, testified today on behalf of the Biotechnology Industry...
14th Annual BIO CEO & Investor Conference to Highlight 2012 Investment Outlook, New Business Models and Key Therapeutic Topics
Jan 31 2012
WASHINGTON, D.C. (January 31, 2012) –The Biotechnology Industry Organization (BIO) announces plenary sessions, Business Roundtables and Therapeutic...


Biotechnology News

BIO Applauds Sen. Stabenow’s Grow It Here, Make It Here Initiative
February 20, 2012

WASHINGTON--(BUSINESS WIRE)--BIO applauds Grow It Here, Make It Here legislation, introduced by Sen. Debbie Stabenow (D-Mich.) in Detroit today, that will provide tax...

Cubist Pharmaceuticals to Present at February/March Investor Conferences
February 20, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that company management will present at investor conferences during February...

Xerox Helps Healthcare Providers, Payers and States Prioritize Patient Safety
February 20, 2012

LAS VEGAS--(BUSINESS WIRE)--Healthcare organizations and state agencies are increasingly turning to Xerox (NYSE: XRX) to help tackle their growing list of IT and federal...

Takeda Announces Primary Endpoints Met for Pivotal Phase 3 Trial of Vedolizumab in Patients with Moderately to Severely Active Ulcerative Colitis Who Have Failed at Least One Conventional Therapy
February 20, 2012

OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502) today announced top-line results from the international, randomized, placebo-controlled,...

Suppliers Participating in Comparative Effectiveness Research Program to Determine Safest, Most Efficient Care
February 20, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--Baxter International Inc., Deltex Medical and Nihon Kohden America Inc. have been selected to participate in the second phase of a...